nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

03.11.2022 | Letter to the Editor

On the factors affecting the liver SUV in [¹⁸F]FDG PET/CT imaging

verfasst von: Eric Laffon, Henri de Clermont, Roger Marthan

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Zwezerijnen GJC, et al. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-022-05977-5. Online ahead of print.

Chiaravalloti A, et al. Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging. 2014;41(6):1123–32. https://doi.org/10.1007/s00259-014-2703-0.CrossRef

Laffon E, de Clermont H, Lamare F, Marthan R. Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship. Eur J Nucl Med Mol Imaging. 2015;42(1):164–5. https://doi.org/10.1007/s00259-014-2925-1.CrossRef

Chiaravalloti A, Schillaci O. Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship. Eur J Nucl Med Mol Imaging. 2015;42(1):166. https://doi.org/10.1007/s00259-014-2926-0.CrossRef

Laffon E, de Clermont H, Lamare F, Marthan R. Estimating the amount of FDG uptake in physiological tissues. Nucl Med Biol. 2014;41(9):717–20. https://doi.org/10.1016/j.nucmedbio.2014.06.003.CrossRef

Laffon E, Marthan R. The total amount of uptake may affect the input function: a theoretic approach about 18F-FDG PET imaging. Nucl Med Biol. 2015;42(9):724–7. https://doi.org/10.1016/j.nucmedbio.2015.04.006.CrossRef

Titel: On the factors affecting the liver SUV in [18F]FDG PET/CT imaging
verfasst von: Eric Laffon
Henri de Clermont
Roger Marthan
Publikationsdatum: 03.11.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-022-06026-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2023

Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head

Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound

Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications

Predicting pathological highly invasive lung cancer from preoperative [18F]FDG PET/CT with multiple machine learning models

Authors’ reply to Dr. Paolo Duarte: Combined [68Ga]Ga-PSMA-11 and low-dose [18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy